Botox
This treatment may use medicines or injectable products that have not been approved under Japan’s Pharmaceuticals and Medical Devices Act. The following information is provided in accordance with the MHLW Medical Advertising Guidelines.
-
1. Unapproved medicine
The products used in this treatment may include "Botulax, Coretox", medicines or injectable products not approved in Japan.
-
2. Acquisition route
Our clinic obtains these products as products of "Hugel, Inc. (Botulax), Medytox, Inc. (Coretox)" (South Korea) via personal importation, and uses them under the responsibility of the attending physician.
-
3. Domestically approved alternatives
There may be no domestically approved product with the same ingredient and purpose.
Domestically approved products used for similar purposes include: BOTOX VISTA (botulinum toxin type A product, Allergan Japan K.K., approved on January 21, 2009; available at our clinic).
-
4. Safety information from other countries
Approval status in other countries: Korea Ministry of Food and Drug Safety (MFDS)
Botulax and Coretox have not received approval in Japan under the Pharmaceuticals and Medical Devices Act. For the treatment of frown lines between the eyebrows and crow's feet, you can choose Allergan's BOTOX VISTA, a medicine approved in Japan, at our clinic. Botulax has been approved by the Korea MFDS. In the United States, a product with the same active ingredient from the same company received FDA approval in 2024 under a different brand name (Letybo). This is not an approval of the product Botulax itself. Coretox is approved only by the Korea MFDS and has no approval in the United States or Europe. For personally imported medicines, there is no official guarantee that their manufacturing, quality, and safety are equivalent to those of medicines approved in Japan. For this intended use, safety information is limited, and significant risks may not yet have been identified. If health damage occurs, it is also not covered by Japan's Adverse Drug Reaction Relief System.
For pharmaceutical products that have not been approved in major Western countries, safety information is limited, and significant risks may not yet have been identified.
※ Unapproved pharmaceutical products used in this treatment are not covered by Japan's Adverse Drug Reaction Relief System in the event of any health damage.